Dr Reddy's Laboratories Ltd

NYSE:RDY

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RDY's stock price target?

Price Target

15.24 USD

According to Wall Street analysts, the average 1-year price target for RDY is 15.24 USD with a low forecast of 11.63 USD and a high forecast of 19.07 USD.

What is Dr Reddy's Laboratories Ltd's Revenue forecast?

Projected CAGR

7%

For the last 13 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's revenue is 10%. The projected CAGR for the next 3 years is 7%.

What is Dr Reddy's Laboratories Ltd's Operating Income forecast?

Projected CAGR

-1%

For the last 13 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's operating income is 10%. The projected CAGR for the next 3 years is -1%.

What is Dr Reddy's Laboratories Ltd's Net Income forecast?

Projected CAGR

-1%

For the last 13 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's net income is 12%. The projected CAGR for the next 3 years is -1%.